NCT00346827已完成2 期
Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 36
研究概览
简要总结
To determine the safety and tolerability of repeated dosing with Apomorphine Nasal Powder in subjects with Parkinson's Disease.
研究设计
- 研究类型
- Interventional
- 干预模型
- Sequential
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •1 year history of Parkinson's Disease; stable PD medications for 4 weeks; at least one documented "off" period per day
排除标准
- •hypersensitivity to apomorphine; participation in a clinical trial in the last 12 weeks; pregnant or lactating females
研究者
相似试验
已完成
不适用
Evaluation of the Nonmotor Symptomatology of Parkinsonian Patients Treated With Two Strategies Related to Apomorphine Pump Therapy in French HospitalsParkinson DiseaseNCT03693872Rennes University Hospital43
招募中
不适用
Parkinsonian Patients Treated With Apomorphine Pump: Observatory of Skin LesionsPatients With Parkinson's Disease Treated With Apomorphine PumpsNCT05331573University Hospital, Rouen108
尚未招募
不适用
Efficacy of drug therapies in post-nasal dripKCT0004740Chungbuk National University Hospital80
已完成
1 期
Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly and and Healthy Younger Adult ParticipantsHealthyNCT02345148Janssen Research & Development, LLC16
已完成
2 期
Study Examining PrEP-001 in Healthy SubjectsInfluenza A H3N2NCT03220048Hvivo66